| Literature DB >> 27329442 |
Graham Ambrose1, Ashraf Amlani1, Jane A Buxton2.
Abstract
OBJECTIVES: This study sought to identify factors that may be associated with help-seeking by witnesses during overdoses where naloxone is administered.Entities:
Keywords: ACCIDENT & EMERGENCY MEDICINE; PUBLIC HEALTH
Mesh:
Substances:
Year: 2016 PMID: 27329442 PMCID: PMC4916577 DOI: 10.1136/bmjopen-2016-011224
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Demographic characteristics of clients who indicated whether or not 911 was called (n=164)
| Variable | Number of responses* | (%)* |
|---|---|---|
| Sex, all participants (n=132) | ||
| Male | 77 | 58.33% |
| Female | 55 | 41.67% |
| Sex, responders (n=93) | ||
| Male | 56 | 60.22% |
| Female | 37 | 39.78% |
| Sex, role not indicated (n=39) | ||
| Male | 21 | 53.85% |
| Female | 18 | 46.15% |
| Age, year (n=91) | ||
| Mean, all participants (range) | 39.78 | (20–80) |
| Mean, responders (range) | 39.32 | (21–80) |
| Mean, role not indicated (range) | 40.92 | (20–60) |
*Except where otherwise indicated.
Calling 911 by reported demographic and overdose characteristics
| Variable | Number of (%) responses | Number of (%) called 911 | Number of (%) did not call 911 n=75 |
|---|---|---|---|
| Age (of person completing administration form) | 91 (100.00) | 50 (54.95) | 41 (45.05) |
| 20–30 | 29 (31.87) | 18 (62.07) | 11 (37.93) |
| 31–41 | 16 (17.58) | 8 (50.00) | 8 (50.00) |
| 42–46 | 23 (25.27) | 16 (69.57) | 7 (30.43) |
| 47–80 | 23 (25.27) | 8 (34.78) | 15 (65.22) |
| Sex (of person completing administration form) | 132 (100.00) | 72 (54.55) | 60 (45.45) |
| Male | 77 (58.33) | 36 (46.75) | 41 (53.25) |
| Female | 55 (41.67) | 36 (65.45) | 19 (34.55) |
| Health authority | 162 (100.00) | 88 (54.32) | 74 (45.68) |
| Vancouver Coastal Health | 67 (41.36) | 44 (65.67) | 23 (34.33) |
| Interior Health | 44 (27.16) | 10 (22.73) | 34 (77.27) |
| Fraser Health | 39 (24.07) | 27 (69.23) | 12 (30.77) |
| Island Health | 11 (6.79) | 7 (63.64) | 4 (36.36) |
| Northern Health | 1 (0.62) | 0 (0.00) | 1 (100.00) |
| Overdose setting | 158 (100.00) | 81 (51.27) | 77 (48.73) |
| Private residence | 80 (50.63) | 22 (27.50) | 58 (72.50) |
| On the street | 37 (23.42) | 30 (81.08) | 7 (18.92) |
| Hotel | 14 (8.86) | 8 (57.14) | 6 (42.86) |
| Other | 11 (6.96) | 7 (63.64) | 4 (36.36) |
| Shelter | 8 (5.06) | 8 (100.00) | 0 (0.00) |
| Supportive housing | 8 (5.06) | 6 (75.00) | 2 (25.00) |
| Programme period (weeks) | 150 (100.00) | 85 (56.67) | 65 (43.33) |
| <69.4 | 41 (27.33) | 19 (46.34) | 22 (53.66) |
| ≥69.4 | 109 (72.67) | 66 (60.55) | 43 (39.45) |
| Number of ampoules administered | 151 (100.00) | 82 (54.30) | 69 (45.70) |
| 1 | 86 (56.95) | 44 (51.16) | 42 (48.84) |
| 2 | 64 (42.38) | 37 (57.81) | 27 (42.19) |
| 3 | 1 (0.66) | 1 (100.00) | 0 (0.00) |
| Withdrawal symptoms | 139 (100.00) | 73 (52.52) | 66 (47.48) |
| None | 72 (51.80) | 45 (62.50) | 27 (37.50) |
| Mild | 47 (33.81) | 18 (38.30) | 29 (61.70) |
| Severe | 20 (14.39) | 10 (50.00) | 10 (50.00) |
| Aggression | 132 (100.00) | 75 (56.82) | 57 (43.18) |
| No | 105 (79.55) | 63 (60.00) | 42 (40.00) |
| Yes | 27 (20.45) | 12 (44.44) | 15 (55.56) |
| Number of substances involved | 158 (100.00) | 86 (54.43) | 72 (45.57) |
| 1 | 85 (53.80) | 48 (56.47) | 37 (43.53) |
| 2 | 50 (31.65) | 31 (62.00) | 19 (38.00) |
| 3 | 17 (10.76) | 3 (17.65) | 14 (82.35) |
| ≥4 | 6 (3.80) | 4 (66.67) | 2 (33.33) |
| Substances involved* | 158 (100) | – | – |
| Heroin | 142 (89.87) | 78 (54.93) | 64 (45.07) |
| Fentanyl | 35 (22.15) | 18 (51.43) | 17 (48.57) |
| Morphine | 11 (6.96) | 5 (45.45) | 6 (54.55) |
| Methadone | 9 (5.70) | 2 (22.22) | 7 (77.78) |
| Codeine | 4 (2.53) | 0 (0.00) | 4 (100.00) |
| Oxycodone | 4 (2.53) | 4 (100.00) | 0 (0.00) |
| Hydromorphone | 1 (0.63) | 0 (0.00) | 1 (100.00) |
| Methamphetamine | 16 (10.13) | 7 (43.75) | 9 (56.25) |
| Cocaine | 16 (10.13) | 5 (31.25) | 11 (68.75) |
| Alcohol | 16 (10.13) | 9 (56.25) | 7 (43.75) |
| Benzodiazepine | 6 (3.80) | 4 (66.67) | 2 (33.33) |
| GHB (gamma-hydroxybutyrate) | 1 (0.63) | 1 (100.00) | 0 (0.00) |
| Other | 2 (1.27) | 0 (0.00) | 2 (100.00) |
| Role | 164 (100.00) | 89 (54.27) | 75 (45.73) |
| Responded | 112 (68.29) | 64 (57.14) | 48 (42.86) |
| Not indicated | 52 (31.71) | 25 (48.08) | 27 (51.92) |
*Total numbers and percentages not shown for all columns as responses totalled more than 100% of participants.
Unadjusted and adjusted odds of Calling 911 during overdoses where naloxone is administered
| Overdose characteristics | Unadjusted OR | 95% | p Value | Adjusted OR* | 95% CI | p Value |
|---|---|---|---|---|---|---|
| Age | ||||||
| 20–30 | Ref | |||||
| 31–40 | 0.64 | (0.18 to 2.31) | 0.50 | |||
| 41–46 | 1.48 | (0.45 to 5.06) | 0.52 | |||
| 47–80 | 1.21 | (0.38 to 4.01) | 0.75 | |||
| Sex | ||||||
| Male | Ref | Ref | ||||
| Female | 2.16 | (1.06 to 4.49) | 0.04 | 2.42 | (0.88 to 7.05) | 0.10 |
| Health authority | ||||||
| Vancouver coastal health | Ref | Ref | ||||
| Interior health | 0.15 | (0.06 to 0.36) | <0.001 | 0.30 | (0.06 to 1.20) | 0.10 |
| Other† | 1.05 | (0.48 to 2.29) | 0.91 | 0.86 | (0.28 to 2.57) | 0.8 |
| Overdose setting | ||||||
| Private residence‡ | Ref | Ref | ||||
| On the street | 7.26 | (3.01 to 19.74) | <0.0001 | 10.68 | (2.83 to 51.87) | <0.01 |
| Other§ | 5.93 | (2.28 to 17.61) | <0.001 | 3.89 | (1.03 to 16.47) | 0.05 |
| Person who overdosed used more than one drug | ||||||
| No | Ref | |||||
| Yes | 0.75 | (0.39 to 1.40) | 0.37 | |||
| Person who overdosed used more than one opioid | ||||||
| No | Ref | |||||
| Yes | 0.75 | (0.36 to 1.54) | 0.43 | |||
| Person who overdosed used a stimulant¶ | ||||||
| No | Ref | Ref | ||||
| Yes | 0.46 | (0.20 to 1.02) | 0.06 | 0.32 | (0.09 to 0.98) | 0.05 |
| Person who overdosed used a depressant (other than an opioid)** | ||||||
| No | Ref | |||||
| Yes | 1.25 | (0.50 3.24) | 0.63 | |||
| Naloxone programme period (weeks) | ||||||
| <69.4 | Ref | Ref | ||||
| ≥69.4 | 1.90 | (0.91 to 4.01) | 0.09 | 1.56 | (0.41 to 6.00) | 0.51 |
| No. of ampoules administered | ||||||
| <2 | Ref | |||||
| ≥2 | 1.28 | (0.67 to 2.47) | 0.46 | |||
| Aggression | ||||||
| No | Ref | |||||
| Yes | 0.53 | (0.22 to 1.26) | 0.15 | |||
| Withdrawal symptoms | ||||||
| None | Ref | Ref | ||||
| Mild | 0.37 | (0.17 to 0.79) | 0.01 | 0.98 | (0.31 to 3.12) | 0.97 |
| Severe | 0.60 | (0.22 to 1.66) | 0.32 | 0.81 | (0.21 to 3.07) | 0.75 |
| Role | ||||||
| Responded | Ref | Ref | ||||
| Not indicated | 0.69 | (0.35 to 1.35) | 0.28 | 1.81 | (0.58 to 5.86) | 0.31 |
*Multivariate analysis conducted on n=102 complete cases.
†Includes Northern Health, Fraser Health and Island Health.
‡Includes responses of ‘private residence’ and ‘hotel’.
§Includes shelter, supportive housing and responses of ‘other’.
¶Includes methamphetamine, crack, cocaine.
**Includes alcohol, benzodiazepines, GHB.